technica.bio / Polish Biotech Scene
Poland's biotech scene, mapped.
Polish Biotech Scene
Poland's clinical-stage drugmakers, diagnostics & AI-discovery platforms
From Kraków oncology labs to Warsaw mRNA spinouts — the clinical-stage drugmakers, diagnostics exits, and AI-discovery platforms putting Poland on the global biotech map. Most trade on the Warsaw Stock Exchange (GPW), making the whole scene unusually transparent to track.
Open the interactive Polish Scene →50 companies tracked
| Company | Focus | Stage | HQ | Tier |
|---|---|---|---|---|
| Ryvu Therapeutics | Small-molecule oncology | Phase 2 | Kraków | GPW Main Market |
| Captor Therapeutics | Targeted protein degradation | Phase 1 | Wrocław | GPW Main Market |
| Molecure | First-in-class small molecules | Phase 1 | Warsaw / Łódź | GPW Main Market |
| Celon Pharma | Small molecules & peptides | Phase 3 | Kazuń Nowy | GPW Main Market |
| Pure Biologics | Antibodies & aptamers | Preclinical | Wrocław | GPW Main Market |
| Bioceltix | Veterinary stem-cell therapy | Phase 3 | Wrocław | GPW Main Market |
| Polpharma Biologics | Biosimilar antibodies | Market | Gdańsk / Warsaw | Private / established |
| Mabion | Biologics CDMO | Market | Konstantynów Łódzki | GPW Main Market |
| Scope Fluidics | Molecular diagnostics | Market | Warsaw | GPW Main Market |
| Selvita | Discovery CRO | Market | Kraków | GPW Main Market |
| Ardigen | AI drug discovery | Market | Kraków | Private / established |
| ExploRNA Therapeutics | mRNA technology | Preclinical | Warsaw | Seed / early-stage |
| NanoGroup | Nanoparticle drug delivery | Preclinical | Warsaw | GPW NewConnect |
| Genomtec | Point-of-care molecular dx | Phase 3 | Wrocław | GPW NewConnect |
| Cardiomatics | AI cardiac diagnostics | Market | Kraków | VC-backed (private) |
| Saventic Health | AI diagnostics | Market | Toruń | VC-backed (private) |
| PolTREG | Regulatory T-cell therapy | Phase 2 | Gdańsk | GPW Main Market |
| Bioton | Recombinant insulin & biosimilars | Market | Warsaw | GPW Main Market |
| Adamed Pharma | Small-molecule R&D | Phase 1 | Pieńków | Private / established |
| Proteon Pharmaceuticals | Bacteriophage therapeutics | Market | Łódź | VC-backed (private) |
| Pharmena | 1-MNA small molecule | Phase 1 | Łódź | GPW NewConnect |
| Genomed | Sequencing & gene therapy | Market | Warsaw | GPW NewConnect |
| Warsaw Genomics | Genetic testing | Market | Warsaw | Private / established |
| MNM Bioscience | Neoantigen cancer immunotherapy | Preclinical | Poznań / Cambridge | VC-backed (private) |
| NanoThea | Radiopharma nanoparticles | Preclinical | Warsaw | VC-backed (private) |
| Synektik | Radiopharmaceuticals + robotics | Market | Warsaw | GPW Main Market |
| Braster | Thermography + AI dx | Market | Szeligi | GPW Main Market |
| BioCam | Capsule endoscopy + AI | Phase 3 | Wrocław | VC-backed (private) |
| Nestmedic | Telemedical fetal monitoring | Market | Wrocław | GPW NewConnect |
| StethoMe | AI home stethoscope | Market | Poznań | VC-backed (private) |
| Infermedica | AI triage engine | Market | Wrocław | VC-backed (private) |
| Diagnostyka | Lab diagnostics network | Market | Kraków | GPW Main Market |
| Intelliseq | Genomic bioinformatics | Market | Kraków | Seed / early-stage |
| NapiFeryn BioTech | Plant-protein biotech | Phase 1 | Łódź | Seed / early-stage |
| NanoSanguis | Oxygen-carrier therapeutics | Preclinical | Warsaw | Seed / early-stage |
| Smarter Diagnostics | AI musculoskeletal imaging | Phase 3 | Warsaw | Seed / early-stage |
| Jutro Medical | AI-run primary care | Market | Warsaw | VC-backed (private) |
| SensDx | Electrochemical biosensors | Phase 3 | Warsaw | GPW NewConnect |
| Milton Essex | AI thermal-imaging dx | Phase 2 | Warsaw | GPW Main Market |
| Medicalgorithmics | AI cardiac diagnostics | Market | Warsaw | GPW Main Market |
| Biomed-Lublin | Vaccines & plasma products | Market | Lublin | GPW Main Market |
| FamiCord (PBKM) | Stem-cell banking & therapy | Market | Warsaw | GPW Main Market |
| genXone | NGS sequencing & microbiome | Market | Poznań | GPW NewConnect |
| Read-Gene | Cancer genetics & prevention | Market | Szczecin | GPW NewConnect |
| Urteste | Enzyme-based cancer dx | Phase 2 | Gdańsk | GPW NewConnect |
| BrainScan | AI head-CT diagnostics | Phase 3 | Łódź | Seed / early-stage |
| Imagene.me | AI genome interpretation | Phase 1 | Warsaw | Seed / early-stage |
| Nanores | Nano/micro R&D services | Market | Wrocław | Private / established |
| Balton | Interventional medical devices | Market | Warsaw | Private / established |
| HiProMine | Insect-protein biotech | Phase 3 | Robakowo | VC-backed (private) |
◢ Boom-cycle briefing
Get ahead of the next biotech boom.
New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.
Curated biotech intelligence, compiled for orientation — not investment advice. Company stages, deals and figures move fast; verify against ClinicalTrials.gov, company filings and primary sources before acting.